To determine the clinical relevance of our in vitro observations, we analyzed the expression levels of PPIL2 by immunohistochemistry (IHC) in human breast tissue samples including five normal/pericarcinomatous samples, nine fibroadenoma samples, and 34 ductal carcinoma samples. Here, PPIL2 is linked to breast ductal adenocarcinoma.